These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Adenosine diphosphate-induced platelet aggregation correlates with platelet activation identified with the use of flow cytometry. García M; Schneider DJ Pathophysiol Haemost Thromb; 2008; 36(2):75-9. PubMed ID: 19127086 [TBL] [Abstract][Full Text] [Related]
23. [Antiaggregant drugs: their pharmacology, mechanism of action and the interpretation of large trials]. Cattaneo M; Mannucci PM G Ital Cardiol; 1990 Jul; 20(7):661-9. PubMed ID: 2147159 [No Abstract] [Full Text] [Related]
30. Effect of exercise on platelet activation during aspirin or clopidogrel intake in healthy men. Hjorth Madsen E; Christiansen MK; Schmidt EB; Poulsen TS; Kristensen SR Platelets; 2009 May; 20(3):177-82. PubMed ID: 19437335 [TBL] [Abstract][Full Text] [Related]
31. The effect of tirofiban on fibrinogen/agonist-induced platelet shape change and aggregation. Jagroop IA; Mikhailidis DP Clin Appl Thromb Hemost; 2008 Jul; 14(3):295-302. PubMed ID: 18445610 [TBL] [Abstract][Full Text] [Related]
32. Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease. Serebruany V; Pokov I; Kuliczkowski W; Chesebro J; Badimon J Thromb Haemost; 2008 Jul; 100(1):76-82. PubMed ID: 18612541 [TBL] [Abstract][Full Text] [Related]
33. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Serebruany VL; Malinin AI; Pokov AN; Hanley DF Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263 [TBL] [Abstract][Full Text] [Related]
34. Platelet function testing in atherothrombotic disease: steps forward in managing resistance to antiplatelet therapy. Grove EL; Hvas AM; Kristensen SD Kardiol Pol; 2008 Apr; 66(4):478-9. PubMed ID: 19496276 [No Abstract] [Full Text] [Related]
35. Acidic peptides enhanced genistein-dependent inhibition of human platelet aggregation: potential protective effect of digestible peptides plus genistein against atherosclerosis. Borgwardt K; Bonifatius S; Gardemann A Nutr Res; 2008 Aug; 28(8):523-31. PubMed ID: 19083455 [TBL] [Abstract][Full Text] [Related]
36. Protease-activated receptors in cardiovascular health and diseases. Shah R Am Heart J; 2009 Feb; 157(2):253-62. PubMed ID: 19185631 [TBL] [Abstract][Full Text] [Related]
37. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100. Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939 [TBL] [Abstract][Full Text] [Related]
38. Resistance to oral antiplatelet drugs--a Position Paper of the Working Group on antiplatelet drug resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society. Kuliczkowski W; Witkowski A; Watala C; Filipiak KJ; Budaj A; Golanski J; Sitkiewicz D; Pregowski J; Gorski J; Zembala M; Opolski G; Polonski L; Kardiol Pol; 2008 Apr; 66(4):470-6, 480-5. PubMed ID: 18473281 [No Abstract] [Full Text] [Related]
39. The ultimate solution to the problem of aspirin resistance. Kottke BA J Am Coll Cardiol; 2008 Oct; 52(15):1276; author reply 1277. PubMed ID: 18926334 [No Abstract] [Full Text] [Related]
40. Effect of eptifibatide on inflammation during acute pain episodes in sickle cell disease. Brittain JE; Anea C; Desai P; Delaney J; McDonald A; Looney SW; Key NS; Parise LV; Ataga KI Am J Hematol; 2018 Aug; 93(4):E99-E101. PubMed ID: 29322543 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]